Position in TEVA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,509,085
New position
Shares Held
74,058
first reported quarter
Ownership
0.006%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#248
of 673 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026OSSIAM holds $11,530,234 across 7 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (21.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
126,199 | $5,177,944 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
74,058 | $2,509,085 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
43,300 | $2,046,791 | |
| 4 | ZTS |
Zoetis Inc.
|
16,929 | $1,216,517 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
494 | $267,664 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
1,342 | $226,180 | |
| 7 | VTRS |
Viatris Inc
|
5,419 | $86,053 |
All Filings in TEVA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,509,085 | 74,058 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||